MIRA INFORM REPORT

 

 

Report Date :

22.06.2012

 

IDENTIFICATION DETAILS

 

Name :

FORTIS HEALTH MANAGEMENT LIMITED

 

 

Registered Office :

Escorts Heart Institute and Research Centre, Okhla Road, New Delhi – 110025

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

07.04.2008

 

 

Com. Reg. No.:

55-176412

 

 

Capital Investment / Paid-up Capital :

Rs.24.010 Millions

 

 

CIN No.:

[Company Identification No.]

U85110DL2008PLC176412

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

DELF03601D

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is primarily involved in setting up and running of hospitals.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (27)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 930000

 

 

Status :

Recently commence business activity 

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

Comments :

Though the company was incorporated in the year 2008 April, it has recently commenced business activity from 2011. Trade relations are reported as fair. Business is active. Payments are unknown.

 

The company can be considered for business dealings on a safe and secured terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOCATIONS

 

Registered Office :

Escorts Heart Institute and Research Centre, Okhla Road, New Delhi – 110025, India

Tel. No.:

91-11-26825000

Mobile No.:

91-9717044423 (Mr. Anand)

Fax No.:

91-11-42628435

E-Mail :

secretarial@fortishealthcare.com

suresh.kumar@fortishealthcare.com 

 

 

Corporate Office :

Tower A, Unitech Business Park, Block F, South City 1, Sector 41, Gurgaon – 122001, Haryana India

Tel No. :

91-124-4921061

Fax No.:

91-124-4129900

 

 

DIRECTORS

 

As on 19.09.2011

 

Name :

Mr. Daljit Singh

Designation :

Director

Address :

B-6/9, DLF Phase – 1, Gurgaon – 122001, Haryana, India

Date of Birth/Age :

29.01.1953

Date of Appointment :

07.04.2008

DIN No.:

00135414

 

 

Name :

Mr. Yogesh Kumar Sareen

Designation :

Director

Address :

H. No. ES 083, Nirvana Country, Gurgaon – 122004, Haryana, India

Date of Birth/Age :

11.10.1964

Date of Appointment :

07.04.2008

DIN No.:

00884252

 

 

Name :

Mr. Anurag Yadav

Designation :

Director

Address :

21/504. East End Apartments, Mayur Vihar Extn. Phase I, New Delhi – 110096, India

Date of Birth/Age :

20.08.1969

Date of Appointment :

17.03.2011

DIN No.:

02242031

 

 

Name :

Mr. Pawanpreet Singh Ahuja

Designation :

Director

Address :

E-3/3, DLF Phase – I, Gurgaon, Haryana, India

Date of Birth/Age :

26.10.1969

Date of Appointment :

17.03.2011

DIN No.:

02231081

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 19.09.2011

 

Names of Equity Shareholders

 

No. of Equity Shares

 

 

 

Fortis Global Healthcare Infrastructure Pte Limited, Singapore

 

1200000

Kanishka Healthcare Limited, India

 

1199994

Escorts Heart Institute and Research Centre Limited,  India

 

1000

Yogesh Kumar Sareen

(Held as a nominee of Kanishka Healthcare Limited)

 

1

Pankaj Gulati

(Held as a nominee of Kanishka Healthcare Limited)

 

1

Manu Kapila

(Held as a nominee of Kanishka Healthcare Limited)

 

1

Pawan Preet Singh

(Held as a nominee of Kanishka Healthcare Limited)

 

1

Daljit Singh

(Held as a nominee of Kanishka Healthcare Limited)

 

1

Anurag Yadav

(Held as a nominee of Kanishka Healthcare Limited)

 

1

 Total

 

2401000

 

 

Names of Preference Shareholders

 

No. of Preference Shares

 

 

 

Kanishka Healthcare Limited, India

 

29000

Total

 

29000

 

List of Allottees

 

As on 21.10.2011

 

Names of Allottes

 

No. of Allotted

(Equity Shares)

 

 

 

Escorts Heart Institute and Research Centre Limited,  India

 

99000

Total

 

99000

 

As on 19.09.2011

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Bodies corporate

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is primarily involved in setting up and running of hospitals.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

Not Available

 

 

Facilities :

Unsecured Loan

As on

31.03.2011

(Rs. in

Millions)

As on

31.03.2010

(Rs. in

Millions)

 

 

 

Interoperate Loans

5.500

11.563

Total

5.500

11.563

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S. N. Dhawan and Company

Chartered Accountants

Address :

C-37, Connaught Place, New Delhi – 110001, India

PAN.:

AAQFS0580H

 

 

Related Parties :

·         Fortis Healthcare (India) Limited

·         Fortis Healthcare Holdings Limited

·         Fortis Hospotel Limited (Upto March 16, 2011)

·         Religare Enterprises Limited (REL)

·         Religare Securities Limited

·         Religare Finvest Limited

·         Religare Commodities Limited

·         REL Infrafacilities Limited (formerly known as Religare  Realty Limited

·         Religare  Venture Capital Limited

·         Religare  Insurance Broking Limited

·         Religare  Finance Limited

·         Religare  Capital Markets Limited

·         Religare  Macquarie Wealth Management Limited

·         Religare  Health Insurance Company Limited

·         Religare Arts Initiative Limited

·         Religare  United Soccer Limited

·         Religare  Arts Investment Management Limited

·         AEGON Religare  Life Insurance Company Limited

·         Vistaar Religare  Capital Advisors Limited

·         Religare  Asset Management Company Limited

·         Religare  Trustee Company Limited

·         Mausam Films Limited

·         Vistaar Religare  Films Limited

·         Vistaar Religare  Media Limited

·         Vistaar Religare  Pictures Limited

·         Vistaar Reliqare Entertainment Limited

·         Milestone Religare  Investment Advisors Private Limited

·         Religare  Housing Development Finance Corporation Limited (Formerly know Religare  Advisory Services Limited

·         Religare  Capital Markets Plc.

·         Hichens, Harrison (Middle East) Limited

·         Hichens, Harrison (Ventures) Limited

·         Religare  Capital Markets (UK) Limited

·         Religare  Hichens Harrison Consultoria International Ltda

·         Religare  Capital Markets Pty Limited

·         Religare  Capital Markets Inc

·         London Wall Nominees Limited

·         HH1803.Com Limited

·         Tobler (Mauritius) Limited

·         Tobler (UK) Limited

·         Religare  Global Asset Management Japan Copmay Limited

·         Religare  Investment Advisory (Mauritius)

·         Religare  Investment Holdings (UK) Limited

·         Charterpace Limited Blamire Limited

·         Hichens, Harrison (Far East) Pte Limited

·         Dion Global Solutions Limited

·         Religare  Technologies Limited

·         Regius Overseas Holding Co. Limited,

·         Dion Global Solutions Pty Limited,

·         Dion Global Solutions (Australia) Pty Limited

·         Dion Global Solutions (Development) Pty Limited,

·         Dion Global Solutions (Asia Pacific) Pty Limited

·         Dion Global Solutions (NZ) Limited

·         Dion Global Solutions (HK) Limited

·         Dion Global Solutions (UK) Limited

·         Dion Global Solutions (MY) Sdn Bhd

·         Dion Global Solutions (Singapore) Pte. Limited

·         Religare  Technova Global Solutions Vietnam Company Limited

·         Super Religare  Laboratories Limited

·         MENA Healthcare Investment Company Limited

·         Medical Management Company Limited

·         Super Religare  Laboratories International Limited

·         Super Religare  Laboratories International FZ-LLC

·         Super Religare  Reference Laboratories (Nepal) Private Limited

·         RHC Holding Private Limited Oscar Investments Limited

·         A -1 Book Company Private Limited

·         Malav Holdings Private Limited

·         Luxury Farms Private Limited

·         Vistas Realtors Private Limited

·         Shivi Holdings Private Limited

·         Greenview Buildtech Private Limited

·         RC Nursery (Private) Limited,

·         Shimal Research Laboratories Limited

·         Hospitalia Informations Systems (Private) Limited

·         ANR Securities Limited.

·         Bindas Realtors Private Limited

·         Vistas Complexes Private Limited

·         Meadows Buildtech Private Limited

·         Fortis Clinical Research Limited

·         Green Biofuels Farms Private Limited

·         Malsh Healthcare (Partnership Firm)

·         Oscar Traders (Partnership Firm)

·         Religare Voyages Limited

·         Religare Aviation Limited

·         Religare Aviation Training Academy Limited

·         Religare Travels (India) Limited

·         Religare Bullion Limited

·         Religare Aviation Engineering Limited

·         Religare Flyslms Limited

·         Religare Share Brokers Limited

·         Pirarnal Diagnostic Services Private Limited

·         DDRC Pirarnal Diagnostic Services Private Limited

·         Religare Global Asset Management (HK) Limited

·         Religare Capital Markets (EMEA) Limited

·         Kyte Management Limited

·         Religare Capital Markets (USA) LLC

·         Religare Capital Markets (Hongkong) Limited

·         Religare Capital Markets (Singapore) Pte Limited

·         Religare Voyages Business Services Private Limited

 


 

CAPITAL STRUCTURE

 

After 19.09.2011

 

Authorised Capital : Rs.45.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2500000

Equity Shares

Rs.10/- each

Rs.25.000 Millions

29000

Preference Shares 

Rs.10/- each

Rs.0.290 Million

 

 

 

Rs.25.290 Millions

 

As on 19.09.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3500000

Equity Shares

Rs.10/- each

Rs.35.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2401000

Equity Shares

Rs.10/- each

Rs.24.010 Millions

29000

Preference Shares 

Rs.10/- each

Rs.0.290 Million

 

 

 

Rs.24.300 Millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

24.010

0.500

0.500

2] Share Application Money

4.900

0.000

0.000

3] Reserves & Surplus

211.590

0.000

0.000

4] (Accumulated Losses)

(8.237)

(5.799)

(2.824)

NETWORTH

232.263

(5.299)

(2.324)

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

5.500

11.563

3.128

TOTAL BORROWING

5.500

11.563

3.128

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

237.763

6.264

0.804

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

64.361

0.000

0.000

Capital work-in-progress

0.000

0.000

0.000

Goodwill on acquisition

165.996

0.000

 

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

2.795

0.000

0.000

 

Sundry Debtors

10.260

0.000

0.000

 

Cash & Bank Balances

240.140

0.112

0.000

 

Other Current Assets

0.410

0.000

0.000

 

Loans & Advances

4.652

6.207

1.951

Total Current Assets

258.257

6.319

1.951

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

247.336

0.006

0.072

 

Other Current Liabilities

2.493

0.000

1.046

 

Provisions

1.022

0.049

0.029

Total Current Liabilities

250.851

0.055

1.147

Net Current Assets

7.406

6.264

0.804

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

237.763

6.264

0.804

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income / Consultancy Charges 

0.398

0.000

0.200

 

 

Other Income

0.028

0.000

0.000

 

 

TOTAL                                     (A)

0.426

0.000

0.200

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Medical Consumable and Pharmacy

0.159

0.000

0.000

 

 

Personnel Expenses

1.305

1.697

2.476

 

 

Operating Expenses 

0.230

0.000

0.000

 

 

Selling, General and Administrative Expenses 

0.275

0.192

0.419

 

 

TOTAL                                     (B)

1.969

1.889

2.895

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

(1.543)

(1.889)

(2.695)

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

0.834

1.087

0.128

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

(2.377)

(2.976)

(2.823)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

0.061

0.000

0.000

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

(2.438)

(2.976)

(2.823)

 

 

 

 

 

Less

TAX                                                                  (I)

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

(2.438)

(2.976)

(2.823)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(5.799)

(2.823)

0.000

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(8.237)

(5.799)

(2.823)

 

 

 

 

 

 

Earnings Per Share (Rs.)

(1.02)

--

--

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

(572.30)

0.00

(1411.50)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

(612.56)

0.00

(1411.50)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(0.76)

(47.10)

(144.70)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.01)

0.56

1.21

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

110.37

(2.19)

(1.84)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.03

114.89

1.70

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

No

5) Type of Business

Yes

6) Line of Business•

Yes

7) Promoter’s background

Yes

8) No. of employees

No

9) Name of person contacted

No

10) Designation of contact person

No

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No

15) Capital in the business

Yes

16) Details of sister concerns

Yes

17) Major suppliers

No

18) Major customers

No

19) Payments terms

No

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter

--

23) Banking Details

No

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 

BACKGROUND:

 

Subject was incorporated on April 7, 2008 as a wholly owned subsidiary of Fortis Hospotel Limited ('FHTL'). The Company entered into a business transfer agreement with Fortis Hospitals Limited on March 28, 2011 to acquire the business division consisting of Nagarbhavi Hospital situated at Bangalore, on a going concern slump sale basis. The business of the hospital has been transferred to the Company on March 29, 2011.

 

FINANCIAL PERFORMANCE AND OPERATIONS

 

The Company was incorporated on April 7, 2008 and is primarily involved in setting up and running of hospitals.

The Company is in its initial stages of operations and is in the phase of exploring new business opportunities. During the year, the Company acquired a hospital located at Nagarbhavi, Bangalore from Fortis Hospitals Limited for a consideration of Rs 235.000 Millions. (The deal was consummated on 28,tt March 2011.

The Company has recorded total revenue of Rs.0.426 Millios during the year due to acquisition of the hospital located at Nagarbhavi, Bangalore.

 

 

FIXED ASSETS:

 

·         Leasehold Improvements

·         Plant and Machinery 

·         Medical Equipments

·         Furniture and Fixtures

·         Computers

·         Office Equipments

·         Vehicles  

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.56.42

UK Pound

1

Rs.88.45

Euro

1

Rs.71.52

 

 

INFORMATION DETAILS

 

Report Prepared by :

BSN


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.